IPP Bureau
Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
By IPP Bureau - June 18, 2026
CEO Stéphane Bancel framed the changes as essential to scaling the business
Siegfried opens major API manufacturing facility in Germany
By IPP Bureau - June 18, 2026
The expansion adds 100 m³ of reactor capacity, significantly strengthening Siegfried’s position among the world’s leading CDMOs for small-molecule drug substances
Pharma PLI scheme attracted Rs. 42,694 crore investments, created 1.13 lakh jobs in 6 years: Govt
By IPP Bureau - June 18, 2026
As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation
Suven reports positive Phase 2b results for Ropanicant in major depressive disorder
By IPP Bureau - June 18, 2026
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
AbbVie's Allergan wins FDA nod for first injectable targeting neck lines
By IPP Bureau - June 18, 2026
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
Bayer seals $300 million Perfuse deal
By IPP Bureau - June 18, 2026
Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline
Avio Smart appoints Sandeep Pandya to lead global healthcare expansion
By IPP Bureau - June 18, 2026
Veteran healthcare executive to drive international growth, strategic partnerships, and global commercialization of the company's molecular diagnostics portfolio
Lupin secures 180-day exclusivity for generic Azilsartan Medoxomil tablets in U.S. market
By IPP Bureau - June 18, 2026
Company introduces bioequivalent version of Edarbi for hypertension treatment following U.S. FDA approval; product recorded annual U.S. sales of USD 53.5 million
Brinton Pharma appoints Sathya Narayanan as CEO – India and JPAC
By IPP Bureau - June 18, 2026
Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets
IMA and Abbott declare June 21 as Vitamin D Day of India
By IPP Bureau - June 18, 2026
New annual observance aims to promote safe sun exposure, screening, and preventive healthcare as nearly 77% of Indians are estimated to be Vitamin D deficient
proRITHM named among top 4 AI-based healthcare technologies
By IPP Bureau - June 18, 2026
AI-powered remote patient monitoring platform earns recognition at AI in Healthcare 2.0 for advancing continuous, preventive, and personalized healthcare delivery
More men under 50 seeking help for low testosterone: Apollo Spectra Hospital
By IPP Bureau - June 18, 2026
Hospital data reveals a sharp rise in consultations related to hormonal health, erectile dysfunction and male fertility, highlighting growing awareness among younger men.
Indian Pharmacopoeia Commission delegation attends WHO-led international meet in Brazil
By IPP Bureau - June 18, 2026
Highlights India’s advances in pharmacopoeial science, regulatory standards, and global harmonization efforts at the 16th International Meeting of World Pharmacopoeias
ARScience Biotherapeutics appoints Gustavo Mahler as CEO
By IPP Bureau - June 17, 2026
Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management
Glenmark launches generic Methylene Blue Injection in US market
By IPP Bureau - June 17, 2026
Generic launch targets a US$19 million market in United States, strengthening Glenmark’s institutional and injectable product portfolio in North America
